Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes

Aarti Ramanathan(Regeneron (United States)), Christos A. Kyratsous(Regeneron (United States))
PLoS ONE
April 26, 2016
Cited by 32


Related Papers

No related papers found

Powered by citation graph analysis